Abstract
Purpose : Autoimmune factors are involved in some of the cases of reproductive failure. The aim of this paper is to discuss the association between autoantibodies and reproductive failure.
Methods : Literature review of autoantibodies associated with reproductive failure.
Results : Several autoantibodies were found in association with such clinical manifestations, mainly in patients having systemic lupus erythematosus or the antiphospholipid syndrome. These autoantibodies include “classical” antiphospholipid antibodies such as anticardiolipin, anti-β2-glycoprotein-I, antiphosphatidylserine, and antiphosphatidylethanolamine. There are also some “nonclassical” antiphospholipid antibodies directed to prothrombin, thromboplastin, or mitochondrial antibodies of M5 type, which were also found in patients with reproductive failure. Moreover, animal models as well as some human studies support a role for other autoantibodies in these clinical manifestations including antithyroglobulin, antilaminin-1, anti-corpus luteum, antiprolactin, anti-poly(ADP-ribose), and lymphocytotoxic antibodies.
Conclusions : Even though there is not enough data currently to support a firm association between some of these autoantibodies and reproductive failure, future studies are likely to help us determine and expand the number of autoantibodies screened in these patients.
Similar content being viewed by others
References
Shoenfeld Y, Sherer Y, Blank M: Antiphospholipid syndrome in pregnancy—Animal models and clinical implications. Scand J Rheumatol 1998;27(Suppl 107):33–36
Love PE, Santoro SA: Antiphospholipid antibodies: Anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 1990;112:682–697
Ninomiya C, Taniguchi O, Kato T, Hirano T, Hashimoto H, Hirose S: Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus. Intern Med 1992;31:194–199
Shoenfeld Y, Blank M, Sherer Y: Induction and treatment of the antiphospholipid syndrome—Lessons from animal models. Eur J Clin Invest 2001;31:736–740
BlankM, CohenJ, ToderV, Shoenfeld Y: Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci USA 1991;88:3069–3073
Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y: Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992;89:1558–1563
Vogt E, Lyden TW, Rose NS: Monoclonal antiphosphatidylserine antibody induces intrauterine growth retardation in BALB/c mice. Clin Exp Rheum 1992;10:641
Blank M, Tincani A, Shoenfeld Y: Induction of antiphospholipid syndrome in naive mice with purified IgG anti-phosphatidylserine antibodies. J Rheumatol 1994;21:100–104
Yodfat O, Blank M, Krause I, Shoenfeld Y: The pathogenic role of anti-phosphatidylserine antibodies: Active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Clin Immunol Immunopathol 1996;78:14–20
Karmochkine M, Berard M, Piette JC, Cacoub P, Aillaud MF, Harle JR, Godeau P, Boffa MC: Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus 1993;2:157–160
Berard M, Chantome R, Marcelli A, Boffa MC: Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. J Rheumatol 1996;23:1369–1374
Cabral AR, Cabiedes J, Alarcon-Segovia D: Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995;22:1988–1996
Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC: Autoantibodies to β2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: Clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol 1998;25:667–674
Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR: Antibodies to β2-glycoprotein. I: A potential marker of clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. J Rheumatol 1998;25:2131–2134
BlankM, FadenD, TincaniA, KopolovicJ, GoldbergI, GilburdB, AllegriF, BalestrieriG, ValesiniG, ShoenfeldY: Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994;7:441–455
Font J, Lopez-Soto A, Cervera R, Casals FJ, Reverter JC, Munoz FJ, Miret C, Bove A, Ordinas A, Ingelmo M: Antibodies to thromboplastin in systemic lupus erythematosus: Isotype distribution and clinical significance in a series of 92 patients. Thromb Res 1997;86:37–48
Tincani A, Meroni PL, Brucato A, Zanussi C, Allegri F, Mantelli P, Cattaneo R, Balestrieri G: Antiphospholipid and anti mitochondrial type 5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1985;3:321–326
La Rosa L, Covini G, Galperin C, Catelli L, Del Papa N, Reina G, Morabito A, Balestrieri G, Tincani A, Gershwin ME, Meroni PL: Anti-mitochondrial M5 type antibody represents one of serological markers for antiphospholipid syndrome distinct from anticardiolipin and anti-β2 glycoprotein I antibodies. Clin Exp Immunol 1998; 112:144–151
Vaarala O, Puurunen M, Manttari M, Manninen V, Aho K, Palosuo T: Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost 1996;75:456–459
Matalon-Taratkover S, Blank M, Ornoy A, Shoenfeld Y: The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol 2001;45:72–77
Dendrinos S, Papasteriades C, Tarassi K, Christodoulakos G, Prasinos G, Creatsas G: Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 2000;14:270–274
Pasoto SG, Viana VST, Mendonca BB, Yoshinari NH, Bonfa E: Anti-corpus luteum antibody: A novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 1999;26:1087–1093
Leaños A, Pascoe D, Fraga A, Blanco-Favela F: Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 1998;7:398–403
Breshnihan B, Grigor RR, Oliver M, Lewkonia RM, Hughes GR, Lovins RE, Faulk WP: Immunological mechanism for spontaneous abortion in systemic lupus erythematosus. Lancet 1977;10:1205–1207
Kanai Y, Ionishi S, Terashima Y: Antibody to poly (ADP-ribose) is an indicator of obstetric complications in pregnant patients with systemic lupus erythematosus. Immunol Lett 1989;21:217–222
Inagaki J, Matsuura E, Nomizu M, Sugiura-Ogasawara M, Katano K, Kaihara K, Kobayashi K, Yasuda T, Aoki K: IgG antilaminin-1 autoantibody and recurrent miscarriages. Am J Reprod Immunol 2001;45:232–238
Foidart JM, Yaar M, Figueroa A, Wilk A, Brown KS, Liotta LA: Abortion in mice induced by intravenous injection of antibodies to type IV collagen or laminin. Am J Pathol 1983;110:346–357
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sherer, Y., Tartakover-Matalon, S., Blank, M. et al. Multiple Autoantibodies Associated with Autoimmune Reproductive Failure. J Assist Reprod Genet 20, 53–57 (2003). https://doi.org/10.1023/A:1021716623305
Issue Date:
DOI: https://doi.org/10.1023/A:1021716623305